You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
佐力藥業(300181.SZ)子公司佐力百草中藥中藥飲片通過GMP現場檢查
格隆匯 01-15 19:15

格隆匯1月15日丨佐力藥業(300181.SZ)公佈,近日,經公司在浙江省藥品監督管理局網站(http://mpa.zj.gov.cn)查詢,獲悉浙江省藥品監督管理局發佈了“浙江省藥品GMP檢查結果公告(2020年第1號)”,公司控股子公司浙江佐力百草中藥飲片有限公司(“佐力百草中藥”)中藥飲片通過了GMP現場檢查,具體情況如下:

企業名稱:浙江佐力百草中藥飲片有限公司

地址:浙江湖州安吉縣經濟開發區健康醫藥園一號路

檢查範圍:中藥飲片〔(淨制、切制、炒制、炙制、煅制、燙制、制炭、蒸制、煮制、燀制、燉制、發酵),含毒性飲片(淨制、切制、蒸制、煮制、拌制)〕

檢查日期:2019年12月11日至2019年12月13日

檢查結論:按照《藥品管理法(2019年修訂)》及國家藥品監督管理局關於《貫徹實施 <中華人民共和國藥品管理法> 有關事項的公告》(2019年第103號)要求,經現場檢查,公司控股子公司佐力百草中藥符合《藥品生產質量管理規範(2010年修訂)》要求。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account